Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, CVS Health Corp (NYSE: CVS) closed at $68.92 down -0.40% from its previous closing price of $69.20. In other words, the price has decreased by -$0.40 from its previous closing price. On the day, 8.36 million shares were traded. CVS stock price reached its highest trading level at $69.71 during the session, while it also had its lowest trading level at $68.5.
Ratios:
For a deeper understanding of CVS Health Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.85 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.75. For the most recent quarter (mrq), Quick Ratio is recorded 0.60 and its Current Ratio is at 0.81. In the meantime, Its Debt-to-Equity ratio is 1.10 whereas as Long-Term Debt/Eq ratio is at 1.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on February 13, 2025, Upgraded its rating to Outperform and sets its target price to $75 from $55 previously.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 05 ’25 when Clark James David sold 7,513 shares for $66.35 per share. The transaction valued at 498,488 led to the insider holds 8,394 shares of the business.
Clark James David bought 7,513 shares of CVS for $498,489 on Mar 05 ’25. On Feb 18 ’25, another insider, Mahoney Michael F, who serves as the Director of the company, bought 30,000 shares for $66.70 each. As a result, the insider paid 2,001,000 and bolstered with 39,356 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CVS now has a Market Capitalization of 87003226112 and an Enterprise Value of 158990991360. As of this moment, CVS’s Price-to-Earnings (P/E) ratio for their current fiscal year is 18.85, and their Forward P/E ratio for the next fiscal year is 10.00. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.39. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.23 while its Price-to-Book (P/B) ratio in mrq is 1.15. Its current Enterprise Value per Revenue stands at 0.429 whereas that against EBITDA is 12.602.
Stock Price History:
The Beta on a monthly basis for CVS is 0.58, which has changed by 0.0046647787 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, CVS has reached a high of $71.66, while it has fallen to a 52-week low of $43.56. The 50-Day Moving Average of the stock is 6.15%, while the 200-Day Moving Average is calculated to be 17.62%.
Shares Statistics:
For the past three months, CVS has traded an average of 10.94M shares per day and 13896090 over the past ten days. A total of 1.26B shares are outstanding, with a floating share count of 1.26B. Insiders hold about 0.14% of the company’s shares, while institutions hold 84.11% stake in the company. Shares short for CVS as of 1743379200 were 18256861 with a Short Ratio of 1.67, compared to 1740700800 on 20554799. Therefore, it implies a Short% of Shares Outstanding of 18256861 and a Short% of Float of 1.46.
Dividends & Splits
According to the company, the forward annual dividend rate for CVS is 2.66, from 2.66 in the trailing year. Against a Trailing Annual Dividend Yield of 0.03843931The stock’s 5-year Average Dividend Yield is 3.09. The current Payout Ratio is 72.76% for CVS, which recently paid a dividend on 2025-01-23 with an ex-dividend date of 1745280000. Stock splits for the company last occurred on 2005-06-07 when the company split stock in a 2:1 ratio.
